Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             142 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2012
44 S1 p. S49-S54
6 p.
artikel
2 Editorial Board 2012
44 S1 p. i-
1 p.
artikel
3 F-35 Adipocyte-fatty acid binding protein, NAFLD and cardiovascular risk in the elderly Martino, E.
2012
44 S1 p. S43-
1 p.
artikel
4 F-40 A novel metabolic action for the multikinase inhibitor sorafenib: targeting tumor cells through mitochondrial damage Tesori, V.
2012
44 S1 p. S44-
1 p.
artikel
5 F-16 Applicability of international guidelines in the therapeutic algorithm of hepatocellular carcinoma Leoni, S.
2012
44 S1 p. S36-
1 p.
artikel
6 F-31 Berberine ameliorates necroinflammation in experimental steatohepatitis, but is associated with extrahepatic toxicity Vivoli, E.
2012
44 S1 p. S41-
1 p.
artikel
7 F-15 Caveolin-1 and mitochondrial ultrastructural alterations in regenerating rat liver Mastrodonato, M.
2012
44 S1 p. S36-
1 p.
artikel
8 F-47 Clinical and genetic factors of response to antiviral treatment of chronic hepatitis C virus infection Masarone, M.
2012
44 S1 p. S46-S47
2 p.
artikel
9 F-17 Clinical outcome of liver damage in pregnancy: experience from a prospective cohort study Licata, A.
2012
44 S1 p. S36-S37
2 p.
artikel
10 F-11 Combination of radiofrequency ablation and transcatheter arterial chemoembolization improves survival in advanced hepatocellular carcinoma complicating liver cirrhosis Ventura, P.
2012
44 S1 p. S35-
1 p.
artikel
11 F-7 Common criterion vs AKIN criteria in the definition of acute kidney injury in hospitalized patients with cirrhosis and ascites Rosi, S.
2012
44 S1 p. S33-S34
2 p.
artikel
12 F-32 Dietary supplementation with olive oil with or without n-3 PUFA differentially affects inflammation and progression of experimental nonalcoholic steatohepatitis Provenzano, A.
2012
44 S1 p. S42-
1 p.
artikel
13 F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy Caviglia, G.P.
2012
44 S1 p. S42-
1 p.
artikel
14 F-13 Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C Abbati, G.
2012
44 S1 p. S35-
1 p.
artikel
15 F-10 Emodin partially reverts diet-induced steatosis and completely reverts inflammation and redox status imbalance in rats Panera, N.
2012
44 S1 p. S34-S35
2 p.
artikel
16 F-27 Endocannabinoids in advanced cirrhosis: have we picked the right one? Maggioli, C.
2012
44 S1 p. S40-
1 p.
artikel
17 F-12 Epigenetic modulation of CD40 ligand leads to hyper IgM in patients with primary biliary cirrhosis Lleo, A.
2012
44 S1 p. S35-
1 p.
artikel
18 F-18 Etiological and clinical characteristics of patients with liver cirrhosis at the onset of first hepatic decompensation: final results of a prospective multicentre AISF collaborative study (EPASCO) Stroffolini, T.
2012
44 S1 p. S37-
1 p.
artikel
19 F-36 Ex situ liver surgery for the treatment of unresectable tumours: Padova early experience Gringeri, E.
2012
44 S1 p. S43-
1 p.
artikel
20 F-28 Gender and life-style influences on serum gamma-glutamyltransferase levels: time to change the normal range in the general population Zaccherini, G.
2012
44 S1 p. S40-
1 p.
artikel
21 F-42 Gender-specific determinants of response in HCV genotype 1 to current SOC with peg IFN and ribavirin in a practice cohort Di Marco, V.
2012
44 S1 p. S45-
1 p.
artikel
22 F-48 Genetic predictors of response in the treatment of chronic hepatitis C virus infection: interference between SOCS3 and IL28 Russo, R.
2012
44 S1 p. S47-
1 p.
artikel
23 F-46 Graft survival is worse in HCV positive females transplanted with male donor grafts Belli, L.
2012
44 S1 p. S46-
1 p.
artikel
24 F-43 Hepatitis C in IDUs: preliminary results of an observational, multi-centre study on behalf of FederSerD Chiesa, A.
2012
44 S1 p. S45-
1 p.
artikel
25 F-6 High NT-pro-BNP levels are associated with cardiac morpho-functional changes in patients with advanced liver cirrhosis Licata, A.
2012
44 S1 p. S33-
1 p.
artikel
26 F-1 IL28B gene variants and metabolic profile in patients with genotype 1 chronic hepatitis C Rosso, C.
2012
44 S1 p. S32-
1 p.
artikel
27 F-8 Importance of HLA-B in the sustained virological response in patients with chronic hepatitis C treated with peg-IFN and ribavirin Ibrahim, K.J.
2012
44 S1 p. S34-
1 p.
artikel
28 F-50 Increased urinary level of neutrophil gelatinase–associated lipocalin (NGAL) in patients with cirrhosis and type 1 HRS Cavallin, M.
2012
44 S1 p. S47-S48
2 p.
artikel
29 F-26 In-house allele specific PCR method to study the kinetics of resistant variants during nucleos(t)ide analogs treatment in immunocompetent and immunocompromised patients Moriconi, F.
2012
44 S1 p. S40-
1 p.
artikel
30 F-2 Interaction between vitamin D binding protein polymorphisms and vitamin D levels in the prediction of antiviral response in chronic hepatitis C Bitetto, D.
2012
44 S1 p. S32-
1 p.
artikel
31 F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience Ponziani, F.R.
2012
44 S1 p. S38-S39
2 p.
artikel
32 F-14 Lipopolysaccharide-induced tumor necrosis factor-alpha and hepatic stellate cell proliferation and activation Ceccarelli, S.
2012
44 S1 p. S36-
1 p.
artikel
33 F-39 Management of symptomatic osteoporosis after liver transplantation in a real-world setting Valente, G.
2012
44 S1 p. S44-
1 p.
artikel
34 F-41 Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy Piluso, A.
2012
44 S1 p. S44-S45
2 p.
artikel
35 F-3 Notch3 silencing and sorafenib as combinate treatment for human hepatocellular carcinoma Baglioni, M.
2012
44 S1 p. S32-
1 p.
artikel
36 F-49 Overall survival of patients undergoing liver resection for hepatocellular carcinoma may be predicted by KIR2DL5 and HLA Bw4I80 genotyping Cariani, E.
2012
44 S1 p. S47-
1 p.
artikel
37 F-44 Prevalence and aetiology of transaminases abnormalities in the general population of a small Italian town: the Bagnacavallo study Dall'Aglio, A.
2012
44 S1 p. S45-S46
2 p.
artikel
38 F-21 Primary biliary cirrhosis in Lombardia: a lower than expected female-to-male incidence ratio with higher mortality in men Moroni, L.
2012
44 S1 p. S38-
1 p.
artikel
39 F-5 Prospective validation of 2010 AASLD guideline for the diagnosis of 1-2 cm HCC in cirrhotic patients Manini, M.A.
2012
44 S1 p. S33-
1 p.
artikel
40 F-25 Prospective validation of noninvasive methods to assess liver fibrosis in HCV patients after liver transplantation (LT) Gambato, M.
2012
44 S1 p. S39-S40
2 p.
artikel
41 F-45 Rapid virologic response (RVR), IL28B single nucleotide polymorphism (SNP) rs12980275 and HCV genotype are independent predictors of sustained virologic response (SVR) in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin Puoti, M.
2012
44 S1 p. S46-
1 p.
artikel
42 F-22 Recipient serum total and LDL cholesterol concentration at transplant predicts graft survival after liver transplantation independently from MELD score Corradini, S. Ginanni
2012
44 S1 p. S38-
1 p.
artikel
43 F-4 Recipient's vitamin D receptor genetic polymorphisms identify HCV positive liver transplanted patients at lower risk of graft fibrosis progression due to recurrent hepatitis C Bitetto, D.
2012
44 S1 p. S32-S33
2 p.
artikel
44 F-20 Replicative capacity and response to interferon-alpha treatment of HBV isolates belonging to different genotypes Restuccia, A.
2012
44 S1 p. S37-S38
2 p.
artikel
45 F-34 Risk factors for central pontine (CPM) and extrapontine myelinolysis (EPM) in liver transplanted recipients: a single center analysis Crivellin, C.
2012
44 S1 p. S42-
1 p.
artikel
46 F-37 Role of plasmacytoid dendritic cells in liver ischemia/reperfusion injury Castellaneta, A.
2012
44 S1 p. S43-
1 p.
artikel
47 F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma Ponziani, F.R.
2012
44 S1 p. S39-
1 p.
artikel
48 F-9 The I148M PNPLA3 polymorphism is associated with the clinical presentation and prognosis of hepatocellular carcinoma Valenti, L.
2012
44 S1 p. S34-
1 p.
artikel
49 F-30 The receptor CXCR7 contributes to proliferation and migration of hepatic stellate cells Provenzano, A.
2012
44 S1 p. S41-
1 p.
artikel
50 F-38 The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management Faloppi, L.
2012
44 S1 p. S43-S44
2 p.
artikel
51 F-19 The silybin-phospholipids complex counteracts fatty degeneration, nitrosative and oxidative stress in two rodent models of liver steatosis Grattagliano, I.
2012
44 S1 p. S37-
1 p.
artikel
52 F-29 Transarterial chemoembolization (TACE) with doxorubicin-eluting-bead versus conventional TACE in patients listed for liver transplantation: impact on tumor necrosis and post transplant disease-free survival Nicolini, D.
2012
44 S1 p. S41-
1 p.
artikel
53 F-52 US-guided probe positioning does not improve applicability but reduces variability in liver stiffness (FibroScan) measurement Serviddio, G.
2012
44 S1 p. S48-
1 p.
artikel
54 F-51 Virological response and HBV-DNA reduction during therapy with peginterferon alpha-2a (PEG-IFNα-2a) in patients affected by HBeAg-negative chronic hepatitis B Chessa, L.
2012
44 S1 p. S48-
1 p.
artikel
55 OC-28 Behind D-MELD: the role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants Avolio, A.
2012
44 S1 p. S10-
1 p.
artikel
56 OC-18 CD133+ stem cells for the treatment of end stage liver disease Brodosi, L.
2012
44 S1 p. S7-
1 p.
artikel
57 OC-34 Clinical features and outcome of patients with drug-induced autoimmune hepatitis Licata, A.
2012
44 S1 p. S12-
1 p.
artikel
58 OC-32 Costs and quality of life in patients with chronic hepatic diseases: the COME study results Fagiuoli, S.
2012
44 S1 p. S11-
1 p.
artikel
59 OC-27 Hepatic resection versus laparoscopic radiofrequency ablation for “very early” hepatocellular carcinoma Santambrogio, R.
2012
44 S1 p. S9-S10
2 p.
artikel
60 OC-22 Human gallbladder is a highly available source of stem cells with multiple endodermic mature fates potentiality Cardinale, V.
2012
44 S1 p. S8-
1 p.
artikel
61 OC-12 Identification of lamivudine resistant HBV strain rt204V/I in acute hepatitis B in Italy Coppola, N.
2012
44 S1 p. S5-
1 p.
artikel
62 OC-8 IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease Petta, S.
2012
44 S1 p. S3-
1 p.
artikel
63 OC-10 IL28B genotype, differential expression of intrahepatic interferon-stimulated genes and response to PEG-IFN and ribavirin therapy in an Italian prospective cohort of genotype 1 hepatitis C patients in “real life” Testoni, B.
2012
44 S1 p. S4-
1 p.
artikel
64 OC-11 IL28B polymorphism in chronic HBV infection: the CC allele does not correlate with the phase of the infection nor with HBsAg clearance in IFN treated patients Cherubini, B.
2012
44 S1 p. S4-S5
2 p.
artikel
65 OC-9 IL6, IL6-induced miRNAs and HNF1α/HNF4α in the epigenetic control of cccDNA transcription Scisciani, C.
2012
44 S1 p. S4-
1 p.
artikel
66 OC-24 Interaction between cyclosporine and recipient IL-28B rs12979860 C>T genetic polymorphisms in the achievement of sustained viral response for recurrent hepatitis C Bitetto, D.
2012
44 S1 p. S8-S9
2 p.
artikel
67 OC-30 Interleukin-28B (IL-28B) polymorphism has no impact on the long-term outcome of patients with HCV-related cirrhosis: a 15-years retrospective-prospective cohort study Bruno, S.
2012
44 S1 p. S10-S11
2 p.
artikel
68 OC-19 Key role of chymase in the hepatic production of angiotensin II and in the development of experimental liver cirrhosis and its complications Sansoè, G.
2012
44 S1 p. S7-
1 p.
artikel
69 OC-16 Low efficacy of current nucleic acid testing (NAT) assay for the identification of occult HBV infection (OBI) and consequences for safety of blood supply in Italy Spreafico, M.
2012
44 S1 p. S6-
1 p.
artikel
70 OC-31 Low rates of SVR to peg-interferon plus ribavirin in HCV genotype 1 IL28B rs12979860 CC cirrhotic patients without rapid virological response Degasperi, E.
2012
44 S1 p. S11-
1 p.
artikel
71 OC-6 Monocyte/macrophage peribiliary recruitment by Pkhd1-defective cholangiocytes induces expression of αvβ6 integrin on biliary cysts via TGFβ1 and TNFα in congenital hepatic fibrosis Locatelli, L.
2012
44 S1 p. S3-
1 p.
artikel
72 OC-4 Myostatin: a novel modulator of hepatic stellate cell biology Delogu, W.
2012
44 S1 p. S2-
1 p.
artikel
73 OC-7 NK profiles of non-responder and relapser patients with cHCV infection treated with SOC Oliviero, B.
2012
44 S1 p. S3-
1 p.
artikel
74 OC-33 Non-invasive diagnosis of non-alcoholic steatohepatitis by combined cytokeratin-18 apoptotic fragment and elastometry Carenzi, S.
2012
44 S1 p. S11-S12
2 p.
artikel
75 OC-1 PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury: the significance for sclerosing cholangitis Marzioni, M.
2012
44 S1 p. S1-
1 p.
artikel
76 OC-35 PEG-IFN for chronic hepatitis C in clinical practice: the prospective phase of the AIFA study Rosina, F.
2012
44 S1 p. S12-
1 p.
artikel
77 OC-36 Peripheral insulin resistance rather than hepatic is a primary defect in non obese, non diabetic, non dyslipidemic NAFLD patients: correlation with liver damage Mezzabotta, L.
2012
44 S1 p. S12-S13
2 p.
artikel
78 OC-14 Prevalence of occult HBV infection reactivation in a large cohort of Non-Hodgkin Lymphoma (NHL) patients: a retrospective study Masarone, M.
2012
44 S1 p. S5-S6
2 p.
artikel
79 OC-20 Role of real-time shear wave elastography in assessing fibrosis in chronic hepatitis C Ferraioli, G.
2012
44 S1 p. S7-
1 p.
artikel
80 OC-2 Selective reduction in S100A4 nuclear expression by low-dose paclitaxel halts invasiveness of human cholangiocarcinoma cells through a Rac1-independent, Rho-A/Cdc42-dependent mechanism Sambado, L.
2012
44 S1 p. S1-S2
2 p.
artikel
81 OC-5 Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury Arcidiacono, D.
2012
44 S1 p. S2-S3
2 p.
artikel
82 OC-29 Terlipressin and albumin vs midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by A.I.S.F. Cavallin, M.
2012
44 S1 p. S10-
1 p.
artikel
83 OC-17 The A736V TMPRSS6 polymorphism is associated with the penetrance of hereditary hemochromatosis and hepatocellular carcinoma in C282Y+/+ patients Valenti, L.
2012
44 S1 p. S6-
1 p.
artikel
84 OC-21 The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with an SVR Prati, G.M.
2012
44 S1 p. S7-S8
2 p.
artikel
85 OC-26 The emerging impact of HCC-NAFLD in Italy Bellentani, S.
2012
44 S1 p. S9-
1 p.
artikel
86 OC-25 The genetic background differentially affects hepatic necro-inflammation in response to CCL2 in a murine model of steatohepatitis Galastri, S.
2012
44 S1 p. S9-
1 p.
artikel
87 OC-13 The role of VEGF and VEGFR polymorphisms in the prediction of clinical outcome for advanced hepatocellular carcinoma receiving sorafenib Faloppi, L.
2012
44 S1 p. S5-
1 p.
artikel
88 OC-3 Transplantation of adipose tissue-mesenchymal stem cells in rats with acetaminophen-induced liver failure: effects on oxidative stress and JNK activation Salamone, F.
2012
44 S1 p. S2-
1 p.
artikel
89 OC-23 Urinary ethyl glucuronide improves the detection of alcohol consumption in liver transplant candidates and recipients Piano, S.
2012
44 S1 p. S8-
1 p.
artikel
90 OC-15 Videocapsule endoscopy in patients with portal hypertension: small bowel findings before and following transgiugular intrahepatic portosystemic shunt Pentassuglio, I.
2012
44 S1 p. S6-
1 p.
artikel
91 T-40 Alphafetoprotein and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre cohort study Vitale, A.
2012
44 S1 p. S27-
1 p.
artikel
92 T-2 A morphometric and immunohistochemical study to assess the benefit of an SVR in HCV cirrhotic patients D' Ambrosio, R.
2012
44 S1 p. S14-
1 p.
artikel
93 T-13 A new panoramic 3-dimensional US (3D NAV CEUS) for HCC detection during follow up in cirrhotic patients Giangregorio, F.
2012
44 S1 p. S18-
1 p.
artikel
94 T-16 Contrast-enhanced CT scan differentiates hepatocellular carcinoma and intrahepatic cholangiocarcinoma in cirrhosis Iavarone, M.
2012
44 S1 p. S19-
1 p.
artikel
95 T-25 Drug interaction profile of telaprevir Garg, V.
2012
44 S1 p. S22-
1 p.
artikel
96 T-43 DXA assessment of bone mineral content during the first year after liver tranplantation Cenni, A.
2012
44 S1 p. S28-
1 p.
artikel
97 T-11 Early assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusional computed tomography: pilot study Sacco, R.
2012
44 S1 p. S17-
1 p.
artikel
98 T-34 Effect of statin therapy vs diet in hypercholesterolemic patients affected by nonalcoholic steatohepatitis (NASH) Carnelutti, A.
2012
44 S1 p. S25-S26
2 p.
artikel
99 T-31 Effect of the PNPLA3 I148M polymorphism on the outcome of peg-interferon plus ribavirin treatment in chronic hepatitis C Maggioni, P.
2012
44 S1 p. S24-S25
2 p.
artikel
100 T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study Andreone, P.
2012
44 S1 p. S23-
1 p.
artikel
101 T-8 Entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis B from field practice: high efficacy and favorable safety profile over 3 years of treatment Lampertico, P.
2012
44 S1 p. S16-
1 p.
artikel
102 T-45 Fetuin-A is an independent predictor of both NAFLD and coronary artery disease assessed through coronarography Ballestri, S.
2012
44 S1 p. S29-
1 p.
artikel
103 T-42 Functional role and therapeutic potentials of Sonic hedgehog in an experimental model of biliary obstruction Gaetani, E.
2012
44 S1 p. S28-
1 p.
artikel
104 T-44 HCC cell carries cytoplasmatic drug-storing vesicles as chemoresistance mechanism Colombo, F.
2012
44 S1 p. S29-
1 p.
artikel
105 T-5 High sCD36 plasma level is associated with steatosis and its severity in patients with chronic genotype 1 hepatitis C Petta, S.
2012
44 S1 p. S15-
1 p.
artikel
106 T-6 Hyperuricemia is associated with severe steatosis in patients with chronic hepatitis C Petta, S.
2012
44 S1 p. S15-
1 p.
artikel
107 T-26 Impact of anemia and ribavirin dose reduction on SVR to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure in the Phase III REALIZE study Andreone, P.
2012
44 S1 p. S22-S23
2 p.
artikel
108 T-28 Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study Andreone, P.
2012
44 S1 p. S23-S24
2 p.
artikel
109 T-37 Impaired pancreatic duodenal homeobox protein 1 (PDX-1) expression promotes diabetes and hepatocellular carcinoma (HCC) development in mice De Minicis, S.
2012
44 S1 p. S26-
1 p.
artikel
110 T-50 In hepatocellular carcinoma miR-519d is upregulated by p53 and DNA hypomethylation Milazzo, M.
2012
44 S1 p. S31-
1 p.
artikel
111 T-1 Inhibition of chymase-dependent production of kidney angiotensin II improves renal sodium handling and prevents ascites in experimental liver cirrhosis Sansoè, G.
2012
44 S1 p. S14-
1 p.
artikel
112 T-52 Interferon-stimulated gene expression and IL28B genotype predict rapid viral response during standard therapy for chronic hepatitis C Burlone, M.E.
2012
44 S1 p. S31-
1 p.
artikel
113 T-32 In vivo and in vitro models support the therapeutic effects of acycloguanosyl 5’-thymidyltriphosphate for the hepatocellular carcinoma via telomerase activation Tarocchi, M.
2012
44 S1 p. S25-
1 p.
artikel
114 T-46 Is skin toxicity a predictor of better survival of patients with HCC treated with sorafenib? De Santis, A.
2012
44 S1 p. S29-
1 p.
artikel
115 T-33 Knockdown of Ruvbl-1 reduces HCC cells growth in vitro and in a new orthotopic mice model Mello, T.
2012
44 S1 p. S25-
1 p.
artikel
116 T-38 Leading role of SerpinB3 in molecular signatures of worse prognosis in hepatocellular carcinoma Turato, C.
2012
44 S1 p. S27-
1 p.
artikel
117 T-15 Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers Ferrigno, A.
2012
44 S1 p. S18-S19
2 p.
artikel
118 T-41 Major bleeding episodes among patients with HCC during sorafenib treatment: the dark side of a relatively safe drug? De Santis, A.
2012
44 S1 p. S28-
1 p.
artikel
119 T-39 Metal metabolism in patients with hepatic encephalopathy Marano, M.
2012
44 S1 p. S27-
1 p.
artikel
120 T-10 MiR-221/Mdm2/p53 control loop sensitizes hepatocellular carcinoma cells to anti-cancer treatments Fornari, F.
2012
44 S1 p. S17-
1 p.
artikel
121 T-48 NAFLD fibrosis score is associated with cardiovascular disease in patients undergoing coronarography Gentilucci, U. Vespasiani
2012
44 S1 p. S30-
1 p.
artikel
122 T-51 NAFLD to NASH: an experimental study on the early events of fibrosis Barbero-Becerra, V.J.
2012
44 S1 p. S31-
1 p.
artikel
123 T-18 Natural history of primary biliary cirrhosis: experience from a single center in southern Italy Licata, A.
2012
44 S1 p. S19-S20
2 p.
artikel
124 T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study Andreone, P.
2012
44 S1 p. S24-
1 p.
artikel
125 T-30 Preservation of obese rat livers by subnormothermic machine perfusion protects dipeptidylpeptidase–IV activity and expression in the biliary tree Tarantola, E.
2012
44 S1 p. S24-
1 p.
artikel
126 T-3 Ramp-up strategy and long-term results of sorafenib in advanced-stage hepatocellular carcinoma under daily clinical practice conditions Sacco, R.
2012
44 S1 p. S14-
1 p.
artikel
127 T-49 Retreatment with pegylated interferon and ribavirin of HIV-HCV-coinfected patients: a comparative meta-analysis report Basso, M.
2012
44 S1 p. S30-
1 p.
artikel
128 T-24 Retreatment with telaprevir/Peg-IFN/RBV after a short exposure to telaprevir in Phase I studies: interim results from a Phase IIIb rollover trial (C219) Picchio, G.
2012
44 S1 p. S22-
1 p.
artikel
129 T-12 Rods and rings autoantibodies developing in chronic hepatitis C patients treated with peginterferon and ribavirin target inosine-5’-monophosphate dehydrogenase 2 (IMPDH2) Covini, G.
2012
44 S1 p. S17-S18
2 p.
artikel
130 T-36 Role of bacterial translocation in liver fibrosis and HCC development De Minicis, S.
2012
44 S1 p. S26-
1 p.
artikel
131 T-35 SerpinB3 downregulates the proapoptotic p66Shc protein in human hepatoma cells Ruvoletto, M.
2012
44 S1 p. S26-
1 p.
artikel
132 T-21 Single-step balloon-occluded percutaneous radio-frequency thermal ablation (RFA) plus transcatheter arterial chemoembolization (TACE) for treatment of “complex” unresectable hepatocellular carcinoma Iezzi, R.
2012
44 S1 p. S20-S21
2 p.
artikel
133 T-23 Splenic stiffness assessed by ARFI (acoustic radiation force impulse) correlates with portal pressure in liver cirrhosis Borghi, A.
2012
44 S1 p. S21-S22
2 p.
artikel
134 T-17 Sustained virologic response to interferon prevents the lethal consequence of clinical decompensation in patients who develop a hepatocellular carcinoma post antiviral-treatment Bruno, S.
2012
44 S1 p. S19-
1 p.
artikel
135 T-7 The course of bone mineral density in patients with chronic hepatitis B long term treated with nucleos(t)ide analogs: a longitudinal cohort study Viganò, M.
2012
44 S1 p. S15-S16
2 p.
artikel
136 T-22 The effect of liver transplant on fatigue in patients with primary biliary cirrhosis Carbone, M.
2012
44 S1 p. S21-
1 p.
artikel
137 T-47 Thrombocytopenia and neutropenia during peginterferon plus ribavirin combination therapy in cirrhotic patients with HCV infection Iacobellis, A.
2012
44 S1 p. S30-
1 p.
artikel
138 T-4 Thyroid-stimulating hormone serum level, liver thyroid-stimulating hormone-receptor, and severe fibrosis in genotype 1 chronic hepatitis C patients with normal thyroid function Petta, S.
2012
44 S1 p. S15-
1 p.
artikel
139 T-20 Tissue Doppler imaging analysis, a new method for the diagnosis of diastolic dysfunction in cirrhotic cardiomyopathy Barghini, V.
2012
44 S1 p. S20-
1 p.
artikel
140 T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection Coppola, N.
2012
44 S1 p. S18-
1 p.
artikel
141 T-19 Vitamin D–PTH axis in HCV infection Morisco, F.
2012
44 S1 p. S20-
1 p.
artikel
142 T-9 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practice Lampertico, P.
2012
44 S1 p. S16-S17
2 p.
artikel
                             142 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland